Prospect Capital Advisors’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-869,200
Closed -$6.03M 30
2024
Q3
$6.03M Buy
869,200
+405,150
+87% +$3.18M 2.73% 17
2024
Q2
$3.62M Buy
+464,050
New +$3.44M 1.53% 20
2022
Q2
Sell
-333,100
Closed -$6.44M 30
2022
Q1
$6.44M Buy
333,100
+102,500
+44% +$2.35M 2.99% 13
2021
Q4
$7.54M Buy
+230,600
New +$9.28M 2.97% 13

Other funds holding GDRX

Prospect Capital Advisors's GDRX Position: Q4 2024 in Review

Prospect Capital Advisors sold out of GoodRx Holdings (GDRX) in Q4 2024, closing a stake of 869,200 shares — an estimated $6.03M sold.

Prospect Capital Advisors first reported a position in GDRX in Q4 2021 and held it in 4 quarters. The position peaked at $7.54M in Q4 2021. 170 funds tracked by Wall St. Rank hold GDRX as of Q4 2024.

  • Prospect Capital Advisors reported no remaining GoodRx Holdings position as of Q4 2024 after selling out during the quarter.
  • Prospect Capital Advisors sold 869,200 GoodRx Holdings shares in Q4 2024, an estimated $6.03M.
  • Prospect Capital Advisors first reported a position in GoodRx Holdings in Q4 2021 and held it in 4 quarters.
  • Prospect Capital Advisors's GoodRx Holdings position peaked at $7.54M in Q4 2021.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2024.

Based on Prospect Capital Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.